FCA Suit Against Ex-Aegerion Execs Is Likely To Live On
A False Claims Act case against former executives of newly bankrupt Aegerion Pharmaceuticals Inc. will likely survive a motion to dismiss, a Boston federal judge said Friday, suggesting the suit can...To view the full article, register now.
Already a subscriber? Click here to view full article